The median age was 47 years, and all participants were living with overweight or obesity
10.3389/fphar.2020.00567 19 CasajsV.DemkuraP.CivelloP.Gmez LobatoM.MartnezG
Phase 2 and 3 clinical trials have found that premenopausal women with HSDD experienced a greater frequency of satisfying sexual events after self-administering PT-141, compared with women who took a placebo [5]
Based on this, our affiliated healthcare providers can develop a customized plan that may include compounded Semaglutide, Oral Semaglutide, Ozempic, compounded Tirzepatide, Oral Tirzepatide, Mounjaro, Zepbound, or Wegovy, integrated with complementary strategies for metabolic optimization, such as our quick-access supplements like GLP-1 Daily Support and Weight Loss Boost
This stands in contrast to direct HGH administration, which bypasses these regulatory systems